Product
Pirfenidone/Placebo
1 clinical trial
2 indications
Indication
ALIIndication
PreventionClinical trial
Pirfenidone Versus Placebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following Hypofractionated Radiotherapy in Breast Cancer Patients (PRILI): A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study EvaluatingStatus: Recruiting, Estimated PCD: 2024-12-31